[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental NDA for Lynparza (olaparib) in combination with bevacizumab for the ma...[ Price : $8.95]
Federal Register notice: FDA announces a 2/4 public meeting entitled Testing Methods for Asbestos in Talc and Cosmetic Products Co...[ Price : $8.95]
FDA grants Meissa Vaccines a fast track designation for MV-012-968, a vaccine for protection against respiratory syncytial virus i...[ Price : $8.95]
FDA grants Reflow Medical a breakthrough device designation for the Temporary Spur Stent System, a novel retrievable stent technol...[ Price : $8.95]
FDA approves a MicroVention PMA for the FRED (Flow Re-Direction Endoluminal Device) device for treating brain aneurysms.[ Price : $8.95]
The Coalition to Preserve Access to Pharmacogenomics Information petitions FDA urging it to stop enforcement actions against genet...[ Price : $8.95]
Alnylam Pharmaceuticals begins a rolling submission of its NDA for lumasiran, an investigational RNAi therapeutic targeting glycol...[ Price : $8.95]
FDA releases a draft guidance on Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters Premarket Notific...